KRAS mutation status and toxicity of cetuximab, paclitaxel, cisplatin, and concurrent radiation in Chinese patients with locally advanced esophageal squamous cell carcinoma: An open-label, multicenter, phase II study.
J. Yu
No relevant relationships to disclose
X. Meng
No relevant relationships to disclose
J. h. Wang
No relevant relationships to disclose
X. Sun
No relevant relationships to disclose
L. Wang
No relevant relationships to disclose
M. Ye
No relevant relationships to disclose
P. b. Feng
No relevant relationships to disclose
G. y. Zhu
No relevant relationships to disclose
Y. Lu
No relevant relationships to disclose
S. c. Zhu
No relevant relationships to disclose